Ep188: Art Krieg on Innate Immune System Activators for Cancer
The Long Run with Luke Timmerman
00:00
Zola's synthetic retroviral particle approach
Art outlines Zola's strategy to activate TLR7, TLR8, and TLR9 using encapsulated RNA/DNA in lipid particles.
Play episode from 49:01
Transcript
